Research progress in drug therapy for meningiomas
SUN Ya-xue
XIE Chun-mei
ZHAO Geng-shui
ZHANG Wen-chao
Abstract：Meningiomas are common intracranial tumors,and the treatment of recurrent meningiomas that are not suitable for surgery or radiation therapy remains a clinical challenge.Due to a lack of evidence,the drug treatment regimen for meningiomas is largely still in the experimental stage,with limited evidence of therapeutic efficacy and clinical benefit.Currently,the efficacy of cytotoxic drugs,hormone receptor inhibitors,and their analogues is limited,while targeted agents,immune checkpoint inhibitors,tyrosine kinase inhibitors,and epigenetic-related drugs have shown better clinical therapeutic responses.This article summarizes the existing evidence on drug treatment regimens for meningiomas and outlines the current drugs and future prospects under investigation.
Keywords：MeningiomaDrug therapyTargeted drugTyrosine kinase inhibitor againstImmune checkpoint inhibitors
Publication Date：2024-03-25
Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)
Pages：4( 181-184 )